The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | Mount Sinai Hospitals Group, Inc. | 10% Owner | Other(J) | 13.4M | $0.12 | $1.6M |
| Jun 11, 2024 | Jung Joel R | Interim Chief Financial Office | Grant(A) | 60K | — | $0 |
| Apr 24, 2024 | Icahn School Of Medicine At Mount Sinai | 10% Owner | Other(J) | 9.4M | $0.25 | $2.3M |
| Nov 20, 2023 | Doran Howard JR | Chief Business Officer | Grant(A) | 300K | — | $0 |
| Nov 20, 2023 | Mills Christopher | Director, 10% Owner | Grant(A) | 95K | — | $0 |
| Nov 20, 2023 | Parikh Chirag R. | Director | Grant(A) | 95K | — | $0 |
| Nov 20, 2023 | Levangie Daniel J | Director | Grant(A) | 95K | — | $0 |
| Nov 20, 2023 | Coste Catherine | Director | Grant(A) | 95K | — | $0 |
| Jul 10, 2023 | McLain Thomas H | President | Grant(A) | 200K | — | $0 |
| Jul 6, 2023 | Sterling O. James | Chief Financial Officer | Grant(A) | 575K | — | $0 |
| Jul 6, 2023 | Fleming Fergus | Chief Technical Officer, Director | Grant(A) | 353K | — | $0 |
| Jul 6, 2023 | McLain Thomas H | President | Grant(A) | 394K | — | $0 |
| Jul 6, 2023 | McCullough James Renwick | Chief Executive Officer, Director | Grant(A) | 875K | — | $0 |
| Jul 6, 2023 | Coste Catherine | Director | Grant(A) | 190K | — | $0 |
| Jul 6, 2023 | Donovan Michael J. | Chief Medical Officer | Grant(A) | 86K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).